Atypical inflammatory demyelinating lesions and atypical multiple sclerosis

被引:12
|
作者
Ayrignac, X. [1 ]
Carra-Dalliere, C. [1 ]
Labauge, P. [1 ]
机构
[1] Montpellier Univ Hosp, Dept Neurol, 80 Rue Augustin Fliche, F-34295 Montpellier 05, France
关键词
Atypical demyelinating lesions; Balo's concentric sclerosis; Tumefactive demyelination; Acute hemorrhagic; leukoencephalitis; Solitary sclerosis; ACUTE DISSEMINATED ENCEPHALOMYELITIS; BALOS CONCENTRIC SCLEROSIS; MAGNETIC-RESONANCE-SPECTROSCOPY; OPTICA SPECTRUM DISORDER; PROTON MR SPECTROSCOPY; NEUROMYELITIS-OPTICA; RADIOLOGICAL CHARACTERISTICS; CAVITARY LESIONS; TUMEFACTIVE DEMYELINATION; NATURAL-HISTORY;
D O I
10.1016/j.neurol.2018.03.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atypical idiopathic inflammatory demyelinating disorders (IIDDs) of the brain have long been known to be disorders closely related to multiple sclerosis (MS), despite having distinctive clinical and radiological characteristics. Originally, they mostly corresponded to acute-onset variants of MS that classically had poor prognoses, such as Balo's concentric sclerosis, Marburg variant of MS and Schilder's disease, and their relationship with MS was based on their shared pathological findings and the co-occurrence of these variants in patients with typical MS. More recently, other atypical disorders, such as solitary sclerosis, have also been described as belonging to the MS spectrum, raising the question of their links with MS. Meanwhile, multiple MS mimics have been described and need to be considered in the differential diagnosis of MS. In addition, thorough characterization of these atypical entities, including advanced MRI and biological studies, is now warranted to further improve their management. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:408 / 418
页数:11
相关论文
共 50 条
  • [31] Aggressive atypical multiple sclerosis
    Domingues, J.
    Santos, G.
    Matos, A.
    Sousa, L.
    JOURNAL OF NEUROLOGY, 2011, 258 : 93 - 94
  • [32] Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis
    De Keyser, Jacques
    Laureys, Guy
    Demol, Frauke
    Wilczak, Nadine
    Mostert, Jop
    Clinckers, Ralph
    NEUROCHEMISTRY INTERNATIONAL, 2010, 57 (04) : 446 - 450
  • [33] An atypical case of multiple sclerosis
    Burr, CW
    McCarthy, DJ
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1900, 27 : 634 - 642
  • [34] Atypical presentation of multiple sclerosis
    Acebal-Montero, A.
    Santos-Bueso, E.
    Fernandez-Vigo, J. I.
    Avalos-Franco, N.
    Porta-Etessam, J.
    Garcia-Sanchez, J.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2016, 39 (01): : E5 - E8
  • [35] Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis
    W. G. Branton
    J. Q. Lu
    M. G. Surette
    R. A. Holt
    J. Lind
    J. D. Laman
    C. Power
    Scientific Reports, 6
  • [36] Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders
    Bauer, Angelika
    Hegen, Harald
    Reindl, Markus
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024, 24 (04) : 283 - 297
  • [37] Higher cerebral dysfunction in a case with atypical multiple sclerosis with concentric lesions
    Morioka, C
    Nameta, K
    Komatsu, Y
    Tsujio, T
    Kondo, H
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1996, 50 (01) : 41 - 44
  • [38] CLASSIFICATION OF ATYPICAL AND ASYMPTOMATIC CONTRAST ENHANCING LESIONS IN MULTIPLE-SCLEROSIS
    SEARS, ES
    FAYLE, R
    BIGELOW, R
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1981, 5 (06) : 941 - 941
  • [39] Atypical MOG antibody disease presenting with typical multiple sclerosis lesions
    Dolbec, Katelyn
    Chalkley, Joshua
    Sudhakar, Padmaja
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [40] Tumefactive Demyelinating Lesions in Multiple Sclerosis
    Tamas, Olivera
    Kovacevic, Marija
    Saranovic, Jelena
    Veselinovic, Nikola
    Budimkic, Maja
    Jovicevic, Vanja
    Momcilovic, Nikola
    Andabaka, Marko
    Vitkovic, Jelena
    Mesaros, Sarlota
    Drulovic, Jelena
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 689 - 689